Giv′at-Shmuel, Israel

Michael Belkin


 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Belkin: Innovator in Eye Treatment Technologies

Introduction

Michael Belkin is a notable inventor based in Giv′at-Shmuel, Israel. He has made significant contributions to the field of ophthalmology through his innovative inventions. With a total of 2 patents, Belkin has focused on developing advanced systems for eye treatment.

Latest Patents

One of his latest patents is for an Automated Capsulotomy system. This system includes a radiation source and a controller that defines a treatment zone on the capsule of an eye. The controller is designed to form an opening in the capsule by irradiating multiple target regions within the treatment zone in an iterative process. This process involves acquiring images of the capsule, designating target regions based on these images, and controlling the radiation source accordingly. Another significant patent is for a System for Glaucoma Treatment. This apparatus includes a probe and a processor, where the probe is positioned adjacent to a patient's eye. It is configured to irradiate the trabecular meshwork of the eye with optical beams, while the processor selects target regions for treatment.

Career Highlights

Michael Belkin has worked with companies such as Belkin Laser Ltd. and Belkin Vision Ltd. These organizations have provided him with a platform to develop and refine his innovative technologies in eye care.

Collaborations

Throughout his career, Belkin has collaborated with professionals like David Zigdon and Ziv Karni. These partnerships have contributed to the advancement of his inventions and the impact they have on eye treatment.

Conclusion

Michael Belkin's work in developing innovative eye treatment technologies showcases his dedication to improving patient care. His patents reflect a commitment to advancing medical technology in ophthalmology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…